Characterization of Nanoparticles with SAXS

Comprehensive SAXS analysis for nanoparticle identification and characterization in solid and liquid matrices — from particle size distribution to internal structure determination.

SAXS for Nanoparticles

At DANNALAB we offer a range of analytical services devoted to the identification and characterization of nanoparticles — both in solid and liquid matrices.

SAXS provides unique insights into nanoscale structure, particle distribution, and surface properties that are critical for pharmaceutical and materials applications.

Analytical Capabilities

The following properties may be investigated using our SAXS methodologies:

Nanoparticle Detection

Confirmation of the presence of nanoparticles in complex matrices, including biological matrices.

Agglomeration Effects

Investigation of particle aggregation and cluster formation in formulations and composites.

Shape & Geometry

Determination of shape and geometrical invariants such as radius of gyration (Rg) and form factors.

Internal Structure

Determination of the inner structure of core‑shell and composite nanoparticles.

Specific Surface Area

Determination of specific surfaces for nanoporous materials — critical for dissolution and bioavailability.

Particle Size Distribution

Accurate determination of particle size and size distribution with analysis of polydispersity.

Types of Nanoparticles

Inorganic Nanoparticles

Characterization of metal oxides, silica, gold, silver, and other inorganic nanoparticles for pharmaceutical and diagnostic applications.

Organic Nanoparticles

Analysis of polymeric nanoparticles, dendrimers, and organic composites.

Core‑Shell Particles

Multi‑layer structure analysis with determination of core and shell dimensions and electron density profiles.

Nanoporous Materials

Pore size distribution, specific surface area, and internal structure of mesoporous materials.

Nanocomposites

Analysis of nanoparticle distribution and organization in polymer matrices (e.g., PMMA/SiO2).

Pharmaceutical Nanoparticles

Drug nanocrystals, amorphous nanoparticles, and API nanoformulations.

Key Parameters & Analysis

Size Distribution

Number‑ and volume‑weighted particle size distributions with polydispersity index.

Radius of Gyration (Rg)

Mass‑weighted average distance from the center of mass — shape‑independent size parameter.

Specific Surface Area

Critical parameter for dissolution rate, bioavailability, and reactivity of nanomaterials.

Form Factor Analysis

Shape determination: spheres, rods, discs, ellipsoids, and complex morphologies.

Structure Factor

Interparticle interactions, spatial correlations, and ordering in concentrated systems.

Fractal Dimension

Analysis of aggregate structure and surface roughness.

SAXS Advantages for Nanoparticles

  • Non‑destructive analysis — samples can be recovered after measurement
  • Native environment — particles analyzed in solution, powder, or matrix without modification
  • Wide size range — from 1 nm to several hundred nanometers
  • Ensemble average — statistically relevant information from billions of particles
  • Minimal sample preparation — simple dilution or powder mounting
  • Quantitative results — absolute intensity calibration for concentration determination
  • Complementary to other methods — combines well with DLS, TEM, AFM, and other techniques

Applications

Pharmaceutical Development

Nanocrystal formulations, controlled release systems, and enhanced bioavailability formulations.

Quality Control

Batch‑to‑batch consistency monitoring, stability studies, and release testing.

Formulation Optimization

Effect of processing parameters, excipients, and storage conditions on nanoparticle properties.

Biosimilars Development

Comparability studies and structural characterization of nanoparticulate systems.

Materials Research

Development of novel nanomaterials for pharmaceutical and medical device applications.

Regulatory Support

Documentation for regulatory submissions with cGMP‑compliant testing and QA‑approved deliverables.

SAXS Method Information

Detailed technical information about our SAXS methods and capabilities.

Learn more about SAXS →

Drug Delivery Systems

SAXS for liposomes, LNPs, and other nanoparticulate delivery carriers.

Drug delivery services →

cGMP Compliance

Full details on our quality system, certifications, and regulatory compliance.

View accreditations →

Discuss Your Nanoparticle Project

Contact our technical team to discuss your nanoparticle characterization needs, request a quote, or get expert advice on SAXS method development.

Request Quote